Literature DB >> 22977611

Loss of heterozygosity analysis of microsatellites on multiple chromosome regions in dysplasia and squamous cell carcinoma of the esophagus.

Ming Liu1, Feng Zhang, Shen Liu, Wen Zhao, Jing Zhu, Xiaoli Zhang.   

Abstract

The objective of this study was to characterize the molecular events in the carcinogenesis of esophageal squamous cell carcinoma (ESCC) and to identify biomarkers for early detection of the disease. Matched precancerous and cancerous tissues resected from 34 esophageal cancer patients from Chongqing, southern China, were compared to evaluate the extent of loss of heterozygosity (LOH). Sixteen microsatellite markers on chromosome regions 3p, 4p, 5q, 8p, 9p, 9q, 11p, 13q and 17p were used for PCR-based LOH analysis. The overall frequency of LOH at the 16 microsatellite loci was significantly increased as the pathological status of the resection specimens changed from low-grade dysplasia (LGD) to high-grade dysplasia (HGD) and SCC (P<0.001). A total of 8 markers showed LOH in the LGD samples. In addition, heterozygosity was regained at 4 loci in the SCC samples of 4 patients, respectively, in comparison to the results for these loci in the HGD samples. The overall rate of LOH increased significantly with the deterioration of the lesions, indicating that tumorigenesis of the esophageal squamous epithelia is a progressive process involving accumulative changes in LOH. The 8 loci showing allelic loss in the LGD samples may be involved in the early-stage tumorigenesis of ESCC, and LOH analysis at these loci may help improve the early detection of this disease. Regain of heterozygosity found in certain patients suggests the possibility of genetic heterogeneity in the tumori-genesis of esophageal cancer.

Entities:  

Year:  2011        PMID: 22977611      PMCID: PMC3440705          DOI: 10.3892/etm.2011.297

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  18 in total

1.  Allelic loss on 13q in esophageal squamous cell carcinomas from northern China.

Authors:  Xiao Ping Huang; Fang Wei; Xiang Yang Liu; Xin Xu; Hai Hu; Bao Sheng Chen; Shu Hua Xia; Yu Sheng Han; Ya Ling Han; Yan Cai; Min Wu; Ming Rong Wang
Journal:  Cancer Lett       Date:  2002-11-08       Impact factor: 8.679

2.  Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma.

Authors:  M Partridge; S Pateromichelakis; E Phillips; G Emilion; J Langdon
Journal:  Clin Cancer Res       Date:  2001-07       Impact factor: 12.531

3.  Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.

Authors:  Dejun Shen; Farzad Nooraie; Yahya Elshimali; Victor Lonsberry; Jianbo He; Shikha Bose; David Chia; David Seligson; Helena R Chang; Lee Goodglick
Journal:  Hum Pathol       Date:  2006-08-10       Impact factor: 3.466

Review 4.  The molecular biology of esophageal adenocarcinoma.

Authors:  Linetta B Koppert; Bas P L Wijnhoven; Herman van Dekken; Hugo W Tilanus; Winand N M Dinjens
Journal:  J Surg Oncol       Date:  2005-12-01       Impact factor: 3.454

5.  Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.

Authors:  N Hu; J Huang; M R Emmert-Buck; Z Z Tang; M J Roth; C Wang; S M Dawsey; G Li; W J Li; Q H Wang; X Y Han; T Ding; C Giffen; A M Goldstein; P R Taylor
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

6.  Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma.

Authors:  Lichun Yang; Alfred C C Leung; Josephine M Y Ko; Paulisally H Y Lo; Johnny C O Tang; Gopesh Srivastava; Mitsuo Oshimura; Eric J Stanbridge; Yataro Daigo; Yusuke Nakamura; Cecilia M C Tang; Kwok W Lau; Simon Law; Maria L Lung
Journal:  Oncogene       Date:  2005-01-20       Impact factor: 9.867

7.  2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers.

Authors:  Ge Zhou; Hongmei Li; Dianne DeCamp; She Chen; Hongjun Shu; Yi Gong; Michael Flaig; John W Gillespie; Nan Hu; Philip R Taylor; Michael R Emmert-Buck; Lance A Liotta; Emanuel F Petricoin; Yingming Zhao
Journal:  Mol Cell Proteomics       Date:  2002-02       Impact factor: 5.911

8.  Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients.

Authors:  S M Dawsey; K J Lewin; F S Liu; G Q Wang; Q Shen
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

9.  Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma.

Authors:  Shun He; Guang-Ming Guo; Fu-Xing Liu; Xiao-Ping Huang; Xin Xu; Yan Cai; Ya-Ling Han; Qi-Min Zhan; Min Wu; Jin-Tang Dong; Gui-Qi Wang; Ming-Rong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-14       Impact factor: 4.553

Review 10.  Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.

Authors:  A Karakosta; Ch Golias; A Charalabopoulos; D Peschos; A Batistatou; K Charalabopoulos
Journal:  J Exp Clin Cancer Res       Date:  2005-12
View more
  4 in total

1.  Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma.

Authors:  Philip R Taylor; Christian C Abnet; Sanford M Dawsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

2.  Localization of substance P (SP)-immunoreactivity in the myenteric plexus of the rat esophagus.

Authors:  Ryo Morishita; Ryoichi Yoshimura; Hiroshi Sakamoto; Hirofumi Kuramoto
Journal:  Histochem Cell Biol       Date:  2022-05-04       Impact factor: 4.304

Review 3.  Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.

Authors:  De-Chen Lin; Ming-Rong Wang; H Phillip Koeffler
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 33.883

4.  Loss of heterozygosity and microsatellite instability as predictive markers among Iranian esophageal cancer patients.

Authors:  Mohammad Mahdi Forghanifard; Elham Emami Vahid; Ezzat Dadkhah; Mehran Gholamin; Samaneh Broumand Noghabi; Martha Ghahraman; Mehdi Farzadnia; Mohammad Reza Abbaszadegan
Journal:  Iran J Basic Med Sci       Date:  2016-07       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.